Ads
related to: drugmaker merck- Sign In
Sigma® Life Science
View contract pricing, get quotes
- Lab Products & Equipment
Shop our huge portfolio of labware
equipment from leading brands.
- Chemical Synthesis
Organic Building Blocks, Catalysts,
Heterocycles, Ligands, and more.
- Register an Account
Get product updates, special offers
Save favorites & shopping lists
- Solvent Center
Our Solvents include HPLC, ACS,
Anhydrous, Reagent Grade and more
- Stockroom Reagents
Solvents, Acids/Bases, Absorbents,
Filter Aids, Drying Agents and more
- Sign In
Search results
Merck's Bridion faces generic threat from drugmaker Hikma
Reuters via Yahoo News· 3 months agoMerck said, on Feb. 5, it received the letter under the Hatch-Waxman Act, through which a company...
Merck Nabs Prometheus Bio For $10.8 Billion As Keytruda Patent Expirations Loom
Investor's Business Daily· 1 year agoMerck is acquiring immunology-focused drugmaker Prometheus Bio in a well-timed $10.8 billion deal...
Merck sues federal government, calling plan to negotiate Medicare drug prices extortion
AP Finance via Yahoo Finance· 12 months agoMerck is suing the federal government over a plan to negotiate Medicare drug prices, calling the...
Merck signs $5.5 billion deal with Daiichi for cancer therapy development
Reuters via Yahoo News· 7 months agoTOKYO (Reuters) -Drugmaker Merck will pay Daiichi Sankyo $5.5 billion to jointly develop three of...
Merck (MRK) to Report Q2 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 2 years agoInvestor focus is likely to be on the sales of Merck's (MRK) blockbuster oncology medicine,...
3 Reasons to Buy Merck Stock
Motley Fool· 8 months agoPharmaceutical giant Merck (NYSE: MRK) has delivered excellent returns to its shareholders over the past 12 months, as last year's downturn did little to...
Merck lifts full-year forecast as Keytruda sales soar
Reuters via Yahoo Finance· 2 years ago(Reuters) -Merck & Co on Thursday reported higher-than-expected third-quarter sales and profit on a...
Merck beats first-quarter expectations on Keytruda, Gardasil strength
Reuters via Yahoo News· 1 year agoMerck's first-quarter sales fell to $14.5 billion from $15.9 billion last year. Excluding items,...
Merck discontinues some cancer drug development with China's Sichuan Kelun
Reuters via Yahoo News· 7 months agoChinese drugmaker Sichuan Kelun Pharmaceutical Co said on Monday that Merck & Co Inc was abandoning...
Merck sees sharp decline in COVID sales for 2023 after strong fourth quarter
Reuters via Yahoo Finance· 1 year agoMerck & Co on Thursday forecast 2023 earnings below Wall Street estimates along with an expected...
